NIH Task Force Finds Compounder Problems are ‘Widespread and Longstanding’

Drug Industry Daily
A A
Following congressional outcry, an NIH task force issued findings that show underlying problems with its now-shuttered drug compounding facilities were “widespread and longstanding,” but did not cause any direct harm to patients.

To View This Article:

Login

Subscribe To Drug Industry Daily